Home Medizin SPT Labtech ernennt neuen Chief Commercial Officer

SPT Labtech ernennt neuen Chief Commercial Officer

von NFI Redaktion

SPT Labtech is pleased to announce the appointment of Morten Frost Norgreen as Chief Commercial Officer (CCO) effective February 1, 2024.

In this newly created position, Morten will drive SPT Labtech’s commitment to understand and exceed customer expectations, and lead the group’s teams in developing solutions that enable more productive scientific research and diagnostic workflows.

Morten joins SPT Labtech from Veracyte Inc., where he served as Chief Commercial Officer for IVD. His extensive background also includes senior leadership positions at Agilent Technologies and IQVIA. With extensive experience in the clinical, diagnostic, and genomics markets, he has successfully achieved revenue growth through the effective implementation of go-to-market strategies.

Kieran Murphy, Executive Chairman at SPT Labtech, comments: „I am delighted to welcome Morten to the group. He brings a unique blend of vision and experience that will be crucial in achieving closer collaboration with our customers. It underpins our commitment to strengthen our position as a leading player in liquid handling, sample management, and automation preparation.“

Morten Frost Norgreen adds: „I am honored to be part of a group that has such a strong reputation for innovation and excellence. I look forward to joining a great team and continuing the momentum that has been created through a relentless focus on creating value for our customers.“

Morten Frost Norgreen

Image Credit: SPT Labtech

Related Posts

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.